Plus   Neg

Roche To Buy Spark Therapeutics For $4.3 Bln Cash - Quick Facts

Roche Holding AG (RHHBY) announced Monday that it has entered into a definitive agreement to acquire biotechnology company Spark Therapeutics Inc. (ONCE) for approximately $4.3 billion.

Roche would acquire Spark at a price of $114.50 per share in an all-cash transaction. This price represents a premium of approximately 122% to Spark' sclosing price on February 22, and a premium of approximately 19% to Spark's' 52 week high share price on July 9, 2018.

The merger agreement has been unanimously approved by the boards of Spark Therapeutics and Roche. The transaction is expected to close in the second quarter.

Under the terms of the merger agreement, Roche will promptly commence a tender offer to acquire all outstanding shares of Spark.

Philadelphia, Pennsylvania-based Spark develops gene therapies with one commercial asset and four programs currently in clinical trials.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration or FDA announced on its website that pharma major Pfizer, Inc. issued recall of two lots of tablets meant to treat acute migraine in adults for concerns over bacteria infection. The pharma company is recalling two lots of Relpax (eletriptan hydrobromide) 40 mg tablets for potential presence of Genus Pseudomonas and Burkholderia bacteria. Cosmetics company Revlon Inc. (REV) is reportedly considering a potential sale of parts or all of its business. According to Bloomberg, Revlon has retained financial advisers from Goldman Sachs Group Inc. to explore strategic alternatives. No deal has been reached yet, but Revlon is exploring all... China's Lenovo Group Ltd. warned it may have to raise prices of its products if the U.S. moves ahead with the decision to impose additional tariffs on Chinese goods, according to a report by Reuters. The warning by Lenovo, the world's largest PC maker, comes amid the escalating trade war between the U.S. and China that has raised concerns about the global economic outlook.
Follow RTT